Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 178

1.

Recent new approaches to the treatment of head and neck cancer.

St John MA, Abemayor E, Wong DT.

Anticancer Drugs. 2006 Apr;17(4):365-75. Review.

PMID:
16549993
2.

Multidisciplinary approaches in the management of advanced head and neck tumors: state of the art.

Gibson MK, Forastiere AA.

Curr Opin Oncol. 2004 May;16(3):220-4. Review.

PMID:
15069316
3.

Emerging drugs for head and neck cancer.

Rhee JC, Khuri FR, Shin DM.

Expert Opin Emerg Drugs. 2004 May;9(1):91-104. Review.

PMID:
15155138
4.

Head and neck cancer: past, present and future.

Chin D, Boyle GM, Porceddu S, Theile DR, Parsons PG, Coman WB.

Expert Rev Anticancer Ther. 2006 Jul;6(7):1111-8. Review.

PMID:
16831082
5.

State-of-the-art management of locally advanced head and neck cancer.

Seiwert TY, Cohen EE.

Br J Cancer. 2005 Apr 25;92(8):1341-8. Review.

6.

Adenoviral gene therapy in head and neck cancer.

Vattemi E, Claudio PP.

Drug News Perspect. 2006 Jul-Aug;19(6):329-37. Review.

PMID:
16971969
7.

Trials and tribulations of immunotherapy as a treatment option for patients with squamous cell carcinoma of the head and neck.

Young MR.

Cancer Immunol Immunother. 2004 May;53(5):375-82. Epub 2003 Nov 22. Review.

PMID:
14634795
8.

Advances in radiation therapy of head and neck cancer.

Popovtzer A, Eisbruch A.

Expert Rev Anticancer Ther. 2008 Apr;8(4):633-44. doi: 10.1586/14737140.8.4.633. Review.

PMID:
18402530
9.

Evidence-based radiation oncology in head and neck squamous cell carcinoma.

Corvò R.

Radiother Oncol. 2007 Oct;85(1):156-70. Epub 2007 May 4. Review.

PMID:
17482300
10.

Targeting epidermal growth factor receptor signaling in the treatment of head and neck cancer.

Astsaturov I, Cohen RB, Harari P.

Expert Rev Anticancer Ther. 2006 Sep;6(9):1179-93. Review.

PMID:
17020453
11.

Integrating novel agents into the curative treatment of head and neck cancer.

Haddad R, Allen A, Wirth L, Tishler R, Posner M.

Expert Rev Anticancer Ther. 2006 Feb;6(2):157-9. No abstract available.

PMID:
16445367
12.

New therapeutic strategies for the treatment and prevention of head and neck cancer.

Lingen MW, Emami B, Clark JI.

Expert Opin Investig Drugs. 2000 Dec;9(12):2855-72. Review.

PMID:
11093357
13.

Expanding role of the medical oncologist in the management of head and neck cancer.

Choong N, Vokes E.

CA Cancer J Clin. 2008 Jan-Feb;58(1):32-53. Epub 2007 Dec 20. Review.

14.

Recent advances in combined modality therapy for locally advanced head and neck cancer.

Wirth LJ, Posner MR.

Curr Cancer Drug Targets. 2007 Nov;7(7):674-80. Review.

PMID:
18045072
15.

INGN 201: Ad-p53, Ad5CMV-p53, adenoviral p53, p53 gene therapy--introgen, RPR/INGN 201.

[No authors listed]

Drugs R D. 2007;8(3):176-87. Review.

PMID:
17472413
16.

Prospects for future studies in head and neck cancer.

van Dongen GA, Snow GB.

Eur J Surg Oncol. 1997 Dec;23(6):486-91. Review.

PMID:
9484916
17.

Altered fractionated radiotherapy in the management of head and neck carcinomas: advantages and limitations.

Bourhis J, Etessami A, Wilbault P, Lusinchi A, Calais G, Lapeyre M, Pignon JP.

Curr Opin Oncol. 2004 May;16(3):215-9. Review.

PMID:
15069315
18.
19.

Neoadjuvant chemotherapy or chemoradiotherapy in head and neck cancer.

Jain P, Kumar P, Pai VR, Parikh PM.

Indian J Cancer. 2008 Jul-Sep;45(3):83-9.

20.

[Information on head, neck and lung cancers].

Dansin E, Lefebvre JL.

Bull Cancer. 2009;96 Suppl 1:S5-11. doi: 10.1684/bdc.2008.0784. Review. French.

PMID:
19433369

Supplemental Content

Support Center